Cardiol Therapeutics (CRDL) PT Raised to $8 at Canaccord Genuity
Tweet Send to a Friend
(Updated - May 23, 2024 6:53 AM EDT)
Canaccord Genuity analyst Edward Nash raised the price target on Cardiol ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash raised the price target on Cardiol ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
